Skip to content

Standing Frames in Cerebral Palsy

Standing Frames as part of Postural Management for Children with spasticity. What is the acceptability of a trial to determine the efficacy of standing frames.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN82916961
Enrollment
500
Registered
2015-10-16
Start date
2016-01-01
Completion date
Unknown
Last updated
2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral palsy Nervous System Diseases Cerebral palsy

Interventions

Participants will be completing surveys and there will be focus groups of parents and professionals and in-depth interviews with young people. Steps include: 1. Survey 1: Professiona
in-depth interviews with children to understand attitudes to standing frame use and acceptability of a trial. 3. Synthesis of findings from survey 1 and qualitative research, and devel

Sponsors

Newcastle Upon Tyne NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Parents of young children using standing frames for cerebral palsy 2. Healthcare professionals working with children who use standing frames 3. Education professionals and other carers working with children who use standing frames 4. Children and young people age 8-18 years who have cerebral palsy GMFCS IV or V and use standing frames

Exclusion criteria

Exclusion criteria: Severe cognitive impairment and/or significant communication difficulties resulting in inability to be able to make simple choices or communicate “yes” vs. “no” responses.

Design outcomes

Primary

MeasureTime frame
1. Description of current standing frame use for children with CP (including treatment indications, treatment goals, types of frame, durations of intended and actual use; perceptions and practicalities of standing frame use) 2. A proposed design (Population- Intervention-Control/comparator-outcome(s) – Timeframe formulation and trial design) for a clinical trial(s) of effectiveness of frames in children with CP, GMFCS levels IV or V

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026